Remibrutinib Clinical Trials
3 recruitingDrug
Phase 32Phase 21
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Chronic Spontaneous Urticaria (CSU)
Novartis Pharmaceuticals400 enrolled128 locationsNCT06868212
Recruiting
Phase 2
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)
Novartis Pharmaceuticals44 enrolled17 locationsNCT06865651
Recruiting
Phase 3
Remibrutinib Open Label Roll-over Post-trial Access Protocol
Indication of the Parent Protocol
Novartis Pharmaceuticals212 enrolled7 locationsNCT07456891